Company filings profile · CIK 0001541157
Akari Therapeutics Plc — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Akari Therapeutics Plc (AKTX): 14 filings in the last 90 days vs 17 in the prior 90 (filing-velocity steady · 0.82×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 2, 2026. Source-linked, daily-refreshed.
Material 8-K events — Akari Therapeutics Plc
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 1, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Aug 13, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 2, 2026 | Item 5.07; Financial Statements and Exhibits | ↗ |
| Jun 26, 2026 | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| May 22, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Mar 17, 2026 | Item 3.03; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 2, 2026 | Item 5.07 | ↗ |
Watch Akari Therapeutics Plc automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 1, 2026 | DEF 14A | DEF 14A | ↗ |
| Oct 1, 2026 | 4 | 4 | ↗ |
| Oct 1, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Aug 19, 2026 | 4 | 4 | ↗ |
| Aug 13, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 13, 2026 | 10-Q | 10-Q | ↗ |
| Aug 12, 2026 | SCHEDULE 13G | ↗ | |
| Aug 7, 2026 | SCHEDULE 13G | ↗ | |
| Aug 5, 2026 | 4 | 4 | ↗ |
| Jul 17, 2026 | 4 | 4 | ↗ |
| Jul 13, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jul 10, 2026 | S-3/A | S-3/A | ↗ |
| Jul 8, 2026 | S-3/A | S-3/A | ↗ |
| Jul 7, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jul 2, 2026 | 8-K | Item 5.07; Financial Statements and Exhibits | ↗ |
| Jul 2, 2026 | S-3 | S-3 | ↗ |
| Jun 26, 2026 | 8-K | Entry into a Material Agreement; Financial Statements and Exhibits | ↗ |
| Jun 26, 2026 | S-1/A | S-1/A | ↗ |
| Jun 25, 2026 | 4 | 4 | ↗ |
| Jun 25, 2026 | 4 | 4 | ↗ |
| Jun 8, 2026 | SCHEDULE 13G | ↗ | |
| Jun 4, 2026 | DEF 14A | DEF 14A | ↗ |
| Jun 3, 2026 | D | Item 06b | ↗ |
| May 22, 2026 | PRE 14A | PRE 14A | ↗ |
| May 22, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 21, 2026 | RW | RW | ↗ |
| May 19, 2026 | 10-Q | 10-Q | ↗ |
| May 18, 2026 | NT 10-Q | NT 10-Q | ↗ |
| May 8, 2026 | S-1 | S-1 | ↗ |
| Apr 15, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Apr 10, 2026 | POS AM | POS AM | ↗ |
| Apr 2, 2026 | DRS | ↗ | |
| Mar 31, 2026 | F-6/A | ↗ | |
| Mar 30, 2026 | 10-K | 10-K | ↗ |
| Mar 17, 2026 | 8-K | Item 3.03; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 16, 2026 | 4 | 4 | ↗ |
| Mar 4, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 4, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 4, 2026 | SCHEDULE 13G/A | ↗ | |
| Mar 2, 2026 | 8-K | Item 5.07 | ↗ |